lhilaryl

ADPT Head and shoulders top

Short
lhilaryl Updated   
NASDAQ:ADPT   Adaptive Biotechnologies Corporation
Broke strong support and uptrend line with a bearish head and shoulders top pattern.
With the current market situation and possible head and shoulders on IXIC, the incentive to short has increased.
Company losing money, EPS down 97.7% Q/Q, and the measly 98.40M sales do not justify a 7.23B market cap.
Of course as always, obey stop loss management principles.
Back to $44
Trade closed: target reached:
First target $44.50 reached strongly, closed half position and seeing future price action for complete exit
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.